Search for: "Novo Nordisk A/S"
Results 181 - 200
of 310
Sorted by Relevance
|
Sort by Date
26 Jun 2023, 6:59 am
This version of insulin is expected to be interchangeable with popular brand-name insulins – Sanofi’s Lantus, Eli Lilly’s Humalog and Novo Nordisk’s Novolog. [read post]
12 Apr 2024, 6:22 am
As of April 2024, there were 74 claims in the Ozempic stomach paralysis lawsuit filed against pharmaceutical manufacturer Novo Nordisk. [read post]
4 Jun 2024, 9:05 pm
At the time of writing, Novo Nordisk also happens to be the most valuable European company. [read post]
26 Jul 2018, 8:53 am
Novo Nordisk A/S, 108 F.3d1361, 1365 (Fed. [read post]
18 Dec 2013, 9:00 pm
To support this burden-shifting standard, the majority cited Novo Nordisk A/S v. [read post]
21 Dec 2006, 12:21 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKIntellectual PropertyCourt Denies Preliminary Injunction Against New, Inhalable Diabetes Treatment Novo Nordisk A/S v. [read post]
12 May 2014, 10:01 pm
Before that, she founded Entotech Inc., a biopesticide subsidiary of Novo Nordisk, the Danish global healthcare company. [read post]
13 Sep 2011, 5:42 am
Novo Nordisk (10-844) — scope of patent protection for overbroad invention claim for new drug Messerschmidt v. [read post]
21 Sep 2011, 7:42 am
Denmark's Novo Nordisk S/A last year stopped shipping certain brands of insulin"Those poor diabetics! [read post]
29 Jun 2011, 7:19 am
Novo Nordisk A/S , U.S., No. 10-844, review granted 6/26/11 ). [read post]
5 Feb 2023, 3:51 pm
AstraZeneca won in the District of Delaware, while Sanofi Aventis and Novo Nordisk lost at the District of New Jersey. [read post]
2 Dec 2011, 6:42 am
Novo Nordisk is scheduled for argument next week on Monday and concerns pharmaceutical litigation under the Hatch-Waxman Act. [read post]
8 Nov 2015, 10:40 am
Novo Nordisk’s Lars Sørensen ranked 6th in financial metrics alone, but when coupled with a good environmental, social and governance performance rating, catapulted him to this year’s top performing CEO. [read post]
28 Oct 2009, 3:54 pm
Novo Nordisk 12. [read post]
27 Jun 2011, 8:16 am
Novo Nordisk A/S (concerning counterclaims under the Hatch-Waxman Act). [read post]
8 Jul 2011, 11:04 am
June 23, 2011), the industry is trying again for clarity in the morass that is the FDA’s current regulation (if it can be called that) of off-label promotion.Earlier this week, seven large drug/device manufacturers (Allergan, Eli Lilly, J&J, Novartis, Novo Nordisk, and Sanofi-Aventis) filed a Citizen Petition with the FDA demanding that the Agency replace its current mish-mash of non-binding guidance documents, letters, press releases, criminal plea agreements,… [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
25 Jan 2011, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Jul 2010, 1:05 am
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation… [read post]
